SOPHiA GENETICS SA Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for SOPHiA GENETICS SA (SOPH) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-61.27-78.98-87.45-3.02-39.34
Depreciation & Amortization8.605.515.573.611.76
Deferred Income Tax-0.73-0.80-1.29-1.600.00
Stock Based Compensation16.4915.2413.618.511.36
Change in Working Capital-2.580.87-1.276.103.82
Change in Accounts Receivable5.89-6.501.331.811.12
Change in Inventory0.07-0.87-0.20-2.340.54
Change in Accounts Payable-7.396.87-1.438.98-0.19
Change in Other Working Capital-5.211.38-0.69-2.332.35
Other Operating Activities-5.215.71-0.69-64.96-0.95
Net Cash from Operating Activities-42.82-48.58-70.09-36.06-31.73
Investing Activities
Capital Expenditures-8.18-1.49-10.382.81-0.45
Purchases of Investments0.0017.55-26.18-50.26-21.12
Sales/Maturities of Investments0.00-7.7378.53-3.99-2.75
Other Investing Activities-7.93-7.470.000.000.00
Net Cash from Investing Activities-8.188.3241.97-78.81-24.32
Financing Activities
Debt Repayment-2.75-3.04-2.32-4.090.00
Common Stock Issued0.410.230.75244.33108.72
Other Financing Activities0.000.000.00-2.470.00
Net Cash from Financing Activities11.59-2.82-1.57237.77107.05
Summary
Effect of Forex Changes on Cash-3.615.02-1.97-4.560.00
Net Change in Cash-39.41-38.05-29.69122.9056.56
Cash at Beginning of Period123.25161.31192.9674.630.00
Cash at End of Period80.23105.71161.31197.530.00
Free Cash Flow-51.00-50.07-80.47-38.87-32.18
Supplemental Disclosures
Interest Paid1.730.010.270.290.86
Income Taxes Paid0.540.800.000.06-0.15